58	120	{'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 1), 'text':'3 .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 4), 'text':'Genetic Pathways Deregulated in Glioblastomas'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 11), 'text':'Although lower-grade gliomas ( II and III ) can undergo malignant progression'}, {'start':(2, 12), 'end':(2, 16), 'text':'to become secondary glioblastoma ,'}]}, {'start':(2, 17), 'end':(2, 32), 'text':'most GBMs are diagnosed as de novo primary glioblastoma without sign of antecedent lower-grade tumor .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 51), 'text':'Primary GBMs typically show gene amplification and mutations of the epidermal growth factor receptor ( EGFR ) , deletion or loss-of-function mutations of the phosphatase and tensin homolog ( PTEN ) at chromosome 10 , and less frequently gene amplification of the p53 inhibitor human double minute 2 ( HDM2 ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 24), 'text':'Deregulation of these pathways is believed to contribute to the self sustained proliferation , resistance to apoptosis , and highly invasive features of glioblastoma .'}, {'start':(5, 0), 'end':(5, 1), 'text':'3.1 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 4), 'text':'Hyperactivation of the EGFR-PI3K-AKT Pathway'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 8), 'text':'The EGFR gene is located on 7p12 .1 ,'}, {'start':(7, 9), 'end':(7, 19), 'text':'which encodes a cell membrane receptor of the ErbB family .'}]}]}]}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 11), 'text':'Upon activation by its ligands EGF or TGFalpha , EGFR undergo homodimerization'}, {'start':(8, 12), 'end':(8, 20), 'text':'to stimulate its intrinsic intracellular protein-tyrosine kinase activity .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 14), 'text':'This triggers the downstream signaling cascades PI3K-AKT-GSK3beta-Rac1 and the Ras-Raf-MEK-ERK ( ) [ ] ,'}, {'start':(9, 15), 'end':(9, 28), 'text':'which controls important functions such as cell survival , proliferation , and motility .'}]}, {'start':(10, 0), 'end':(10, 21), 'text':'Deregulation of EGFR , mostly in the form of gene amplification or overexpression is commonly found in primary GBMs [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 16), 'text':'The majority of GBMs with EGFR amplification also express the variant EGFRvIII [ ] , a mutant'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 17), 'end':(11, 26), 'text':'generated from an in-frame deletion of exons 2 to 7'}, {'start':(11, 27), 'end':(11, 35), 'text':'that results in truncation of the extracellular domain .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 5), 'text':'EGFRvIII is unresponsive to EGF stimulation'}, {'start':(12, 6), 'end':(12, 14), 'text':'but exhibits ligand independent constitutive activity [ ] .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 12), 'text':'These genetic aberrations of EGFR cause activation of PI3K and AKT signalings ,'}, {'start':(13, 13), 'end':(13, 24), 'text':'which promote glioma cell proliferation and tumorigenicity via p27 [ ] .'}]}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 7), 'text':'AKT can also phosphorylate and inhibit GSK3beta ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(14, 8), 'end':(14, 14), 'text':'thereby diminishing proteasomal degradation of cyclin D1'}, {'start':(14, 15), 'end':(14, 23), 'text':'and hence promoting cell cycle progression [ ] .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 17), 'text':'Notably , the levels of phospho-PI3K and phospho-AKT are inversely associated with that of cleaved caspase 3 ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 18), 'end':(15, 29), 'text':'suggesting the association of activated PI3K pathway with reduced level of apoptosis'}, {'start':(15, 30), 'end':(15, 34), 'text':'commonly observed in GBMs .'}]}]}, {'start':(16, 0), 'end':(16, 10), 'text':'This partly accounts for the resistance of glioblastomas to radiotherapy .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 4), 'text':'Ironically , there is evidence'}, {'start':(17, 5), 'end':(17, 12), 'text':'that shows activation of EGFRvIII by radiation ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 13), 'end':(17, 15), 'text':'posing a concern'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 16), 'end':(17, 18), 'text':'in prescribing radiotherapy'}, {'start':(17, 19), 'end':(17, 30), 'text':'as a treatment regimen in the management of glioblastomas [ ] .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 12), 'text':'Furthermore , PI3K and AKT and PKB can activate Rac1 [ ] ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 13), 'end':(18, 23), 'text':'which in turn triggers TIMP2 , MMP2 , and MMP9 pathway'}, {'start':(18, 24), 'end':(18, 30), 'text':'to promote cell invasion [ ] .'}]}]}]}]}]}]}, {'start':(19, 0), 'end':(19, 1), 'text':'3.2 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 13), 'text':'Hyperactivation of the Ras-Raf-MEK-ERK Pathway Causes High Proliferation and Resistance to Apoptosis in Glioblastomas'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 5), 'text':'In addition to PI3K signaling ,'}, {'start':(21, 6), 'end':(21, 13), 'text':'activated EGFR also triggers the Ras-Raf-MEK-ERK pathway .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 6), 'text':'In fact , several growth factor pathways'}, {'start':(22, 7), 'end':(22, 13), 'text':'that are aberrantly activated in glioblastomas ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 14), 'end':(22, 18), 'text':'including platelet derived growth factor'}, {'start':(22, 19), 'end':(22, 26), 'text':'( PDGF ) , insulin like growth factor-1'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 27), 'end':(22, 46), 'text':'( IGF-1 ) , hepatocyte growth factor and scatter factor ( HGF and SF ) , vascular endothelial growth factor'}, {'start':(22, 47), 'end':(22, 50), 'text':'( VEGF ) ,'}]}]}]}, {'start':(22, 51), 'end':(22, 54), 'text':'and transforming growth factor-beta'}]}, {'start':(22, 55), 'end':(22, 63), 'text':'( TGF-beta ) also converge to Ras activation .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'explanation', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(23, 0), 'end':(23, 11), 'text':'High level of activated Ras is always found in glioma cell lines'}, {'start':(23, 12), 'end':(23, 17), 'text':'and glioblastoma biopsies [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 8), 'text':'This is in contrast to many other cancer types'}, {'start':(24, 9), 'end':(24, 17), 'text':'where Ras is abnormally activated by oncogenic mutations .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 8), 'text':'Active Ras recruits Raf kinase to the membrane ,'}, {'start':(25, 9), 'end':(25, 15), 'text':'where it is primed by phosphorylation .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 0), 'end':(26, 7), 'text':'Raf in turn activates MEK and ERK .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 6), 'text':'Activated ERK then translocates into the nucleus'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(27, 7), 'end':(27, 11), 'text':'to activate various transcription factors'}, {'label':'joint', 'direction':'None', 'children':[{'start':(27, 12), 'end':(27, 16), 'text':'to induce cell cycle progression'}, {'start':(27, 17), 'end':(27, 22), 'text':'and antiapoptotic signalings [ ] .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 0), 'end':(28, 13), 'text':'Importantly , blockade of Ras activation in gliomas slows down cancer cell proliferation .'}, {'start':(29, 0), 'end':(29, 13), 'text':'Application of Ras inhibitor also reduces migration of U87-MG gliomas cells [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 0), 'end':(30, 19), 'text':'The deregulation of signalings in gliomas is further complicated by intensive cross-talk between the Ras and the PI3K pathways .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 9), 'text':'Ras is known to stimulate PI3K through physical association ,'}, {'start':(31, 10), 'end':(31, 24), 'text':'which activates PI3K mediated antiapoptotic processes and hence contributes to Ras oncogenicity [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 0), 'end':(32, 14), 'text':'Conversely , PI3K was proposed to participate in ERK1 and 2 activation [ ] .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 0), 'end':(33, 20), 'text':'In summary , aberrant activation of specific receptor tyrosine kinases in gliomas elicits both the Ras and the PI3K cascades ,'}, {'start':(33, 21), 'end':(33, 37), 'text':'leading to promotion of cancer cell proliferation , survival , motility , and resistance to apoptosis .'}]}, {'start':(34, 0), 'end':(34, 1), 'text':'3.3 .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 0), 'end':(35, 7), 'text':'Loss of PTEN Functions Is Associated with Glioblastomas'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(36, 0), 'end':(36, 4), 'text':'Located at 10q23 .3 ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(36, 5), 'end':(36, 10), 'text':'the PTEN gene encodes a protein'}, {'start':(36, 11), 'end':(36, 33), 'text':'that contains a tensin like domain and a catalytic domain at the N-terminus similar to that of the dual-specificity protein tyrosine phosphatases .'}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(37, 0), 'end':(37, 4), 'text':'Interestingly , it was found'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 5), 'end':(37, 18), 'text':'that the phosphatase activity of PTEN exhibits substrate preference towards phosphoinositide such as phosphatidylinositol'}, {'start':(37, 19), 'end':(37, 30), 'text':'( 3,4,5 ) - trisphosphate ( PIP 3 ) [ ] .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 8), 'text':'PIP 3 is an important lipid product of PI3K'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 9), 'end':(38, 21), 'text':'that serves as second messenger for the activation of AKT and PKB ,'}, {'start':(38, 22), 'end':(38, 35), 'text':'which promotes cell proliferation and survival through the inhibition of apoptotic cell death .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 0), 'end':(39, 22), 'text':'The lipid phosphatase activity of PTEN in dephosphorylating PIP 3 into PIP 2 therefore serves as a negative regulator of PI3K signalings .'}, {'start':(40, 0), 'end':(40, 19), 'text':'In addition to cell proliferation and apoptosis , PTEN is also involved in the regulation of glioma cell motility .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 10), 'text':'The central domain of PTEN shows protein tyrosine phosphatase activity ,'}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'start':(41, 11), 'end':(41, 23), 'text':'which directly dephosphorylates focal adhesion kinase ( FAK ) in integrin complex ,'}, {'start':(41, 24), 'end':(41, 34), 'text':'hence inhibiting integrin mediated migration and invasion [ - ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'cause', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(42, 0), 'end':(42, 9), 'text':'Furthermore , PTEN was found to directly dephosphorylate the SH2'}, {'start':(42, 10), 'end':(42, 19), 'text':'containing adaptor protein ( Shc ) upstream of Ras ,'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(42, 20), 'end':(42, 26), 'text':'hence downregulating the Ras/Raf/MEK / ERK pathway'}, {'start':(42, 27), 'end':(42, 38), 'text':'and inhibits cell spreading , migration , and invasion [ ] .'}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(43, 0), 'end':(43, 2), 'text':'Taken together ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 3), 'end':(43, 11), 'text':'PTEN modulates the integrin-FAK and the Shc-Ras-MAPK pathways ,'}, {'start':(43, 12), 'end':(43, 27), 'text':'thereby regulating both random and directional cell motility in glioma cells , respectively [ ] .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(44, 0), 'end':(44, 22), 'text':'Notably , a majority of primary glioblastoma and established glioma cell lines such as U87-MG and U373-MG carry mutations in the PTEN gene'}, {'start':(44, 23), 'end':(44, 33), 'text':'that result in diminished or null expression of the protein ,'}]}, {'start':(44, 34), 'end':(44, 52), 'text':'leading to aberrant activation of AKT [ ] , FAK [ - ] , and Ras in GBMs .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 0), 'end':(45, 20), 'text':'In fact , loss of heterozygosity ( LOH ) 10q is one of the most common genetic aberrations in GBMs .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 0), 'end':(46, 8), 'text':'A complete loss of the entire chromosome 10 ,'}, {'start':(46, 9), 'end':(46, 19), 'text':'where the PTEN gene resides is typical for primary glioblastomas .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(47, 0), 'end':(47, 21), 'text':'The loss of PTEN check on PIP 3 and AKT and PKB signaling pathway in glioma therefore spares the cells from apoptosis'}, {'start':(47, 22), 'end':(47, 27), 'text':'and promote cell cycle progression .'}]}]}]}]}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'start':(48, 0), 'end':(48, 10), 'text':'Deregulation of PTEN functions could also render EGFR kinase-inhibitor therapy ineffective'}, {'start':(48, 11), 'end':(48, 23), 'text':'because of the dissociation of EGFR inhibition from downstream PI3K pathway inhibition .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 0), 'end':(49, 25), 'text':'Conceivably , a compromise of PTEN functions in counteracting FAK and Ras signalings contributes to the high basal cell motility and the progression of glioblastoma .'}, {'start':(50, 0), 'end':(50, 1), 'text':'3.4 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 0), 'end':(51, 1), 'text':'pRB Pathway'}, {'start':(52, 0), 'end':(52, 16), 'text':'The retinoblastoma protein ( pRB ) is encoded by the RB1 gene located at 13q14 .1 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 0), 'end':(53, 5), 'text':'pRB is a tumor suppressor protein'}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'start':(53, 6), 'end':(53, 15), 'text':'that blocks cell cycle progression through G1 into S-phase ,'}, {'start':(53, 16), 'end':(53, 23), 'text':'hence preventing cells from replicating damaged DNA .'}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(54, 0), 'end':(54, 11), 'text':'Mechanistically , pRb forms complexes with transcription factors of the E2F family'}, {'start':(54, 12), 'end':(54, 25), 'text':'and suppresses the coordinated transcription of genes necessary for DNA synthesis [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 0), 'end':(55, 16), 'text':'The pRb and E2F complex also attracts histone deacetylase ( HDAC ) protein to the chromatin ,'}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 17), 'end':(55, 21), 'text':'reducing transcription of S phase'}, {'start':(55, 22), 'end':(55, 24), 'text':'promoting factors ,'}]}, {'start':(55, 25), 'end':(55, 29), 'text':'further suppressing DNA synthesis .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 0), 'end':(56, 19), 'text':'The cell cycle arrest function of pRB is counteracted upon phosphorylation by the cyclin dependent kinases Cdk4 and Cdk6 ,'}, {'start':(56, 20), 'end':(56, 26), 'text':'which form complexes with cyclin D1 ,'}]}, {'start':(56, 27), 'end':(56, 40), 'text':'leading to a release of E2F and hence derepression of cell cycle progression .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(57, 0), 'end':(57, 18), 'text':'Under physiological conditions , the Cdk4 and cyclin-D 1 activity is checked by CDKN2A ( p16 INK4a ) protein'}, {'start':(57, 19), 'end':(57, 24), 'text':'to prevent aberrant cell proliferation .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(58, 0), 'end':(58, 22), 'text':'In cancer states , however , an upregulation of cyclin D1 and Cdk4 , or an inactivation of CDKN2A is often seen ,'}, {'start':(58, 23), 'end':(58, 28), 'text':'leading to uncontrolled cell proliferation .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(59, 0), 'end':(59, 15), 'text':'In fact , the pRB pathway is commonly inactivated in both primary and secondary glioblastomas .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(60, 0), 'end':(60, 21), 'text':'Genetic loss or promoter methylation of RB1 , homozygous deletion of CDKN2A , or amplification of CDK4 frequently occurs in GBMs .'}, {'start':(61, 0), 'end':(61, 10), 'text':'These deregulations contribute to uncontrolled cell cycle progression and tumorigenesis .'}]}]}]}]}]}]}]}]}]}
0	1	{'start':(0, 0), 'end':(0, 8), 'text':'The Role of Semaphorins and Their Receptors in Gliomas'}
120	200	{'label':'topic-change', 'direction':'None', 'children':[{'start':(0, 0), 'end':(0, 1), 'text':'4 .'}, {'label':'topic-change', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 7), 'text':'Involvement of Axon Guidance Molecules in Glioma Progression'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 13), 'text':'In addition to deregulation of the classical growth factor receptors and signaling pathways ,'}, {'start':(2, 14), 'end':(2, 27), 'text':'increasing evidence suggests the involvement of novel players in the progression of gliomas .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(3, 0), 'end':(3, 18), 'text':'Diffused gliomas are known to be highly infiltrative into the surrounding parenchyma of tumor mass even at low-grade .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(4, 0), 'end':(4, 10), 'text':'This poses an immense challenge to clinical management of the disease'}, {'start':(4, 11), 'end':(4, 26), 'text':'and high recurrence rate is commonly observed even after radical surgical resection of the tumor .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(5, 0), 'end':(5, 21), 'text':'Notably , clinical observations revealed a preferential invasion of gliomas along white matter tracts such as the corpus callosum [ ] .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 20), 'text':'Furthermore , cessation of glioma cell migration is often observed at the junction between the white and the grey matter .'}, {'start':(7, 0), 'end':(7, 18), 'text':'These findings suggest the presence of tropic and guidance cues for the invasion of gliomas within the CNS .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(8, 0), 'end':(8, 21), 'text':'In fact , accumulating evidence suggests the involvement of axon guidance molecules such as netrin [ ] , Slit [ ] ,'}, {'start':(8, 22), 'end':(8, 29), 'text':'and semaphorins [ ] in glioma progression .'}]}]}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(9, 0), 'end':(9, 4), 'text':'A recent study has demonstrated'}, {'start':(9, 5), 'end':(9, 19), 'text':'that netrin functions to inhibit glioma cell motility in an autocrine fashion [ ] .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(10, 0), 'end':(10, 27), 'text':'A loss of expression of DCC ( Deleted in Colorectal Carcinoma ) , the receptor for netrin has been found to correlate with glioma progression [ ] .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(11, 0), 'end':(11, 13), 'text':'Similarly , Slit 2 inhibits glioma cell invasion in a Robo dependent manner ,'}, {'start':(11, 14), 'end':(11, 24), 'text':'and its expression is epigenetically downregulated in gliomas [ ] .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 8), 'text':'Semaphorins are amongst the largest family of guidance molecules'}, {'start':(12, 9), 'end':(12, 23), 'text':'that trigger both repulsive and attractive axon guidance functions through different receptors and coreceptors .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(13, 0), 'end':(13, 4), 'text':'Growing body of evidence indicates'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 5), 'end':(13, 18), 'text':'that semaphorins also subserve pro-tumorigenic and tumor suppressor roles in various cancer types ,'}, {'start':(13, 19), 'end':(13, 24), 'text':'including gliomas [ - ] .'}]}]}, {'start':(14, 0), 'end':(14, 1), 'text':'4.1 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(15, 0), 'end':(15, 6), 'text':'Semaphorins and Their Receptors Neuropilins and Plexins'}, {'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 1), 'text':'Semaphorins ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 2), 'end':(16, 6), 'text':'originally identified as guidance cues'}, {'start':(16, 7), 'end':(16, 14), 'text':'that navigate axons in the nervous system ,'}]}]}, {'start':(16, 15), 'end':(16, 29), 'text':'fall into eight subclasses of secreted , membrane glycosylphosphatidyl-inositol ( GPI ) - anchored ,'}]}, {'start':(16, 30), 'end':(16, 35), 'text':'and transmembrane proteins ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(17, 0), 'end':(17, 9), 'text':'Semaphorins are characterized by the presence of a sema domain'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(17, 10), 'end':(17, 19), 'text':'and a PSI ( plexins , semaphorins and integrins )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 20), 'end':(17, 24), 'text':'domain at the N-terminus ,'}, {'start':(17, 25), 'end':(17, 35), 'text':'which are also present in their receptors plexins [ ] .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 5), 'text':'Most family members harbor the immunoglobulin'}, {'start':(18, 6), 'end':(18, 12), 'text':'( Ig ) - like domain ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 13), 'end':(18, 17), 'text':'which is a signature feature'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 18), 'end':(18, 22), 'text':'found in the Ig superfamily'}, {'start':(18, 23), 'end':(18, 32), 'text':'( IgSF ) of cell adhesion or recognition molecules .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 17), 'text':'Class 5 semaphorins are distinctive due to the presence of multiple thrombospondin 1 ( TSP1 ) domains ,'}, {'start':(19, 18), 'end':(19, 32), 'text':'which has been implicated in platelet aggregation , angiogenesis , and tumorigenesis [ ] .'}]}]}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(20, 0), 'end':(20, 17), 'text':'To date , class 3 semaphorins are the most thoroughly studied for their physiological and pathological functions .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(21, 0), 'end':(21, 9), 'text':'Interestingly , members of this class exist in secreted form'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 10), 'end':(21, 23), 'text':'and interact directly with the receptors neuropilin ( Nrp ) -1 or -2 ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(21, 24), 'end':(21, 28), 'text':'which have small intracellular tail'}, {'start':(21, 29), 'end':(21, 40), 'text':'and need to engage plexins as coreceptors for signal transduction functions .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 12), 'text':'Mammalian plexins are classified into four subfamilies plexin-A to -D [ ] ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 13), 'end':(22, 29), 'text':'which share high homology in structural domains such as the sema domain and the cysteine rich motifs'}, {'start':(22, 30), 'end':(22, 34), 'text':'related to c-Met proto-oncogene .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 15), 'text':'Despite this , interactions between different subfamilies of plexins and semaphorins still show differential specificity ,'}, {'start':(23, 16), 'end':(23, 25), 'text':'which trigger different sets of biological functions ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 15), 'text':'A second level of functional specificity is attained by the coupling of plexins with various coreceptors'}, {'start':(24, 16), 'end':(24, 54), 'text':'expressed in a cell- or tissue specific manner , such as neuropilins , L1 adhesion molecule , off-track ( Otk ) , c-Met proto-oncogene , the receptor tyrosine kinase ErbB2 , CD72 , and Tim-2 [ - ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 37), 'text':'These lead to the implication of semaphorins and plexins in a vast array of biological processes beyond axon guidance , such as cell adhesion , cell motility , angiogenesis , immune responses , organogenesis , and tumorigenesis .'}, {'start':(26, 0), 'end':(26, 1), 'text':'4.2 .'}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 5), 'text':'Semaphorins and Their Receptors in Tumorigenesis'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 0), 'end':(28, 20), 'text':'The implication of semaphorins in cancer development was first suggested by the observation of a deletion of chromosomal region 3p21 ,'}, {'start':(28, 21), 'end':(28, 26), 'text':'where Sema3B and Sema3F reside ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 27), 'end':(28, 35), 'text':'in almost all cases of small cell lung cancer'}, {'start':(28, 36), 'end':(28, 42), 'text':'( SCLC ) [ - ] .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(29, 0), 'end':(29, 2), 'text':'Ensuing research revealed'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(29, 3), 'end':(29, 11), 'text':'that many class 3 semaphorins exhibit tumor suppressor function'}, {'label':'joint', 'direction':'None', 'children':[{'start':(29, 12), 'end':(29, 14), 'text':'by inhibiting proliferation'}, {'start':(29, 15), 'end':(29, 23), 'text':'and promoting apoptotic cell death in cancer cells .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 0), 'end':(30, 11), 'text':'Sema3B , for instance induces apoptosis in lung and breast cancer ,'}, {'start':(30, 12), 'end':(30, 29), 'text':'whereas Sema3F shows antiproliferative and antiangiogenic functions in melanoma , lung , breast , and colorectal cancers .'}]}, {'start':(31, 0), 'end':(31, 34), 'text':'In addition , Sema3A and 3F were shown to inhibit cell migration of breast carcinoma and metastasis of melanoma , respectively , through their receptors neuropilins and plexins in an autocrine or paracrine manner .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(32, 0), 'end':(32, 14), 'text':'Sema3A and Nrp -1 and Sema3F and Nrp -2 interactions also block endothelial cell migration'}, {'start':(32, 15), 'end':(32, 22), 'text':'and initiate antiangiogenic signaling cascades [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(33, 0), 'end':(33, 16), 'text':'While Sema3A , 3B , and 3F demonstrate antitumorigenic or antiangiogenic properties in various cancer types ,'}, {'start':(33, 17), 'end':(33, 27), 'text':'other members are implicated in the promotion of tumor progression .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(34, 0), 'end':(34, 13), 'text':'Overexpression of Sema3C in prostate cancer cell lines promotes cell invasion [ ] .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 0), 'end':(35, 11), 'text':'An upregulation of Sema3E transcript has been observed in metastatic human lung'}, {'start':(35, 12), 'end':(35, 16), 'text':'adenocarcinoma cells [ ] .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(36, 0), 'end':(36, 8), 'text':'Expression of Sema3E induces lung metastasis of mammary adenocarcinoma'}, {'start':(36, 9), 'end':(36, 19), 'text':'and promotes migration and growth of endothelial cells [ ] .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 0), 'end':(37, 34), 'text':'While the importance of semaphorins in cancer development is most well characterized in secreted class 3 members , transmembrane semaphorins of class 4 , 5 , and 6 begin to emerge as important players .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 6), 'text':'Sema4D is highly expressed in cell lines'}, {'start':(38, 7), 'end':(38, 18), 'text':'derived from head and neck squamous cell carcinomas ( HNSCCs ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(39, 0), 'end':(39, 5), 'text':'When shed from HNSCC cells ,'}, {'start':(39, 6), 'end':(39, 11), 'text':'Sema4D stimulates endothelial cell migration .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 0), 'end':(40, 18), 'text':'Silencing Sema4D expression by lentiviral shRNA dramatically reduces the size and vascularity of HNSCC tumor xenografts [ ] .'}, {'start':(41, 0), 'end':(41, 8), 'text':'These findings suggest the angiogenic function of Sema4D .'}]}]}]}]}]}, {'start':(42, 0), 'end':(42, 20), 'text':'An overexpression of Sema4D was found to be significantly correlated with lymph node and distant metastasis of pancreatic ductal adenocarcinoma .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(43, 0), 'end':(43, 3), 'text':'In vitro experiments revealed'}, {'label':'joint', 'direction':'None', 'children':[{'start':(43, 4), 'end':(43, 15), 'text':'that stimulation of pancreatic cancer cells with Sema4D triggers its receptor plexin-B1'}, {'start':(43, 16), 'end':(43, 34), 'text':'and leads to the promotion of invasiveness through activation of the MAPK and the AKT pathway [ ] .'}]}]}]}, {'start':(44, 0), 'end':(44, 17), 'text':'In prostate cancers , a significant upregulation of both Sema4D and plexin-B1 has been observed [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 0), 'end':(45, 6), 'text':'Mutations have also been found in plexin-B1'}, {'start':(45, 7), 'end':(45, 15), 'text':'that causes an impairment of its R-RasGAP activity ,'}]}, {'start':(45, 16), 'end':(45, 22), 'text':'hence increasing cell motility and invasion .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 0), 'end':(46, 25), 'text':'In contrast to these oncogenic roles of Sema4D , however , various lines of evidence point to a tumor suppressor role of its receptor plexin-B1 .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 0), 'end':(47, 12), 'text':'For instance , a loss of plexin-B1 expression is associated with poor prognosis'}, {'start':(47, 13), 'end':(47, 20), 'text':'in ER+ breast cancer patients [ ] .'}]}, {'start':(48, 0), 'end':(48, 11), 'text':'Plexin-B1 downregulation is also seen in renal cell carcinoma [ ] .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(49, 0), 'end':(49, 11), 'text':'Tumor suppressor function of plexin-B1 has been demonstrated in melanoma cells ,'}, {'start':(49, 12), 'end':(49, 28), 'text':'and its expression is downregulated by oncogenic B-Raf signaling via MEK and ERK pathway [ ] .'}]}]}]}]}]}]}, {'start':(50, 0), 'end':(50, 12), 'text':'Divergent functions in cancer development is also implicated in class 6 semaphorins .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 0), 'end':(51, 14), 'text':'Sema6A inhibits both bFGF and VEGF and tumor cell line induced neovascularization [ ] ,'}, {'start':(51, 15), 'end':(51, 31), 'text':'whereas an upregulation of Sema6D expression is associated with the development of gastric carcinoma [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 0), 'end':(52, 8), 'text':'A recent study has revealed the role of Sema7A'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 9), 'end':(52, 20), 'text':'in inhibiting cancer cell invasion by inactivation of cofilin through plexin-C1 ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 21), 'end':(52, 31), 'text':'which is consistent with the observation of a downregulation of Sema7A'}, {'start':(52, 32), 'end':(52, 38), 'text':'in metastatic melanoma cells [ ] .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 0), 'end':(53, 20), 'text':'Among other members , class 5 semaphorins are peculiar due to the presence of thrombospondin repeats in the extracellular domain ,'}, {'start':(53, 21), 'end':(53, 33), 'text':'which have been implicated in cancer cell motility and proliferation [ ] .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 0), 'end':(54, 32), 'text':'The expression of semaphorin 5A ( Sema5A ) and its receptor plexin-B3 was shown to be associated with the aggressive nature of pancreatic , prostate , and gastric cancers [ - ] .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 0), 'end':(55, 19), 'text':'Nonetheless , a recent report has demonstrated significant downregulation of Sema5A transcript and protein in nonsmall cell lung carcinoma ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 20), 'end':(55, 28), 'text':'which correlates with poor survival of the patients ,'}, {'start':(55, 29), 'end':(55, 37), 'text':'suggesting potential anticancer effect of Sema5A [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 0), 'end':(56, 6), 'text':'Consistent with this is a recent study'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 7), 'end':(56, 22), 'text':'that reports the presence a novel missense mutation in plexin-B3 in human pancreatic ductal adenocarcinomas ,'}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'start':(56, 23), 'end':(56, 30), 'text':'which prevents interaction with its ligand Sema5A ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(56, 31), 'end':(56, 34), 'text':'hence impairing their signaling'}, {'start':(56, 35), 'end':(56, 42), 'text':'and contributing to tumor progression [ ] .'}]}]}]}]}, {'start':(57, 0), 'end':(57, 1), 'text':'4.3 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(58, 0), 'end':(58, 5), 'text':'Semaphorins and Their Receptors in Gliomagenesis'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(59, 0), 'end':(59, 15), 'text':'The implication of semaphorins , neuropilins , and plexins in gliomagenesis was suggested by their presence'}, {'start':(59, 16), 'end':(59, 22), 'text':'in human glioma cells [ ] .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(60, 0), 'end':(60, 13), 'text':'In particular , the downregulation of Sema6B expression in two human glioblastoma cell lines'}, {'start':(60, 14), 'end':(60, 34), 'text':'when treated with retinoic acid , an antitumor and differentiation inducing agent suggest its involvement in tumor formation [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(61, 0), 'end':(61, 17), 'text':'To date , class 3 semaphorins remain the most well characterized subfamily in the development of gliomas .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(62, 0), 'end':(62, 15), 'text':'An increase in expression of the Sema3B gene was found to be associated with poor prognosis'}, {'start':(62, 16), 'end':(62, 23), 'text':'and survival of glioma patients [ ] .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(63, 0), 'end':(63, 6), 'text':'Yet a later study reported the opposite'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(63, 7), 'end':(63, 19), 'text':'by demonstrating positive correlations of Sema3B , Sema3G and neuropilin-2 with prolonged survival'}, {'start':(63, 20), 'end':(63, 25), 'text':'in glioma patients [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(64, 0), 'end':(64, 16), 'text':'Similarly , a protumorigenic role of Sema3A was implicated by its overexpression in human GBM specimens ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(64, 17), 'end':(64, 22), 'text':'which acts in an autocrine fashion'}, {'start':(64, 23), 'end':(64, 30), 'text':'to promote glioma cell dispersal through neuropilin-1 .'}]}]}, {'start':(65, 0), 'end':(65, 27), 'text':'Silencing Sema3A expression by RNA interference resulted in a significant suppression in migration and an alteration in glioma cell morphology in a Rac1 dependent manner [ ] .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(66, 0), 'end':(66, 5), 'text':'Nonetheless , it should be noted'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(66, 6), 'end':(66, 14), 'text':'that Sema3A exhibits an antiangiogenic effect in meningiomas ,'}, {'start':(66, 15), 'end':(66, 28), 'text':'as evident by the correlation of its high expression with reduced tumor vascularization .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(67, 0), 'end':(67, 14), 'text':'Recurrence of meniginomas is often associated with a decline in Sema3A expression [ ] .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(68, 0), 'end':(68, 8), 'text':'In contrast to Sema3A , in vitro data revealed'}, {'start':(68, 9), 'end':(68, 23), 'text':'that Sema3F inhibits glioma cell migration via RhoA inactivation by p190 RhoGAP [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(69, 0), 'end':(69, 6), 'text':'Frequent deletion of 3p21 in gliomas ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(69, 7), 'end':(69, 15), 'text':'where the Sema3F gene resides could abolish its effect'}, {'start':(69, 16), 'end':(69, 21), 'text':'in counteracting tumor cell motility .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(70, 0), 'end':(70, 27), 'text':'In a related study , low level of Sema3F expression was observed in highly metastatic human tumor cell lines due to Id2 mediated repression of gene transcription ,'}, {'start':(70, 28), 'end':(70, 42), 'text':'which possibly accounts for the enhancement of tumor cell migration and invasion [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(71, 0), 'end':(71, 23), 'text':'Similarly , an overexpression of or an exogenous stimulation by Sema3G in human U251 glioma cells is sufficient to inhibit migration and invasion ,'}, {'start':(71, 24), 'end':(71, 33), 'text':'suggesting a cell autonomous or paracrine mechanism [ ] .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(72, 0), 'end':(72, 23), 'text':'Recently , Sema5A has been shown to suppress human glioma cell migration and invasion in a plexin-B3- and Rac1 dependent manner [ ] .'}, {'start':(73, 0), 'end':(73, 12), 'text':'A downregulation of Sema5A protein is found from low- to high-grade gliomas .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(74, 0), 'end':(74, 17), 'text':'Notably , stimulation of human glioblastoma cells with Sema5A promotes their differentiation from anaplastic to astrocytic morphology ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(74, 18), 'end':(74, 28), 'text':'which is reminiscent of the less pleomorphic and well differentiated features'}, {'start':(74, 29), 'end':(74, 33), 'text':'associated with low-grade astrocytomas .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(75, 0), 'end':(75, 2), 'text':'Taken together ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(75, 3), 'end':(75, 5), 'text':'these findings suggest'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(75, 6), 'end':(75, 12), 'text':'a tumor suppressor role of Sema5A ,'}, {'start':(75, 13), 'end':(75, 21), 'text':'which is compromised towards high-grade glioblastomas [ ] .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(76, 0), 'end':(76, 8), 'text':'In addition to semaphorins , there has been evidence'}, {'start':(76, 9), 'end':(76, 18), 'text':'pointing to the importance of neuropilins in glioma development .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(77, 0), 'end':(77, 18), 'text':'Analyses of human glioma specimens revealed a significant correlation of Nrp-1 expression with glioma progression to high grades .'}, {'start':(78, 0), 'end':(78, 17), 'text':'An upregulation of Nrp-1 in glioma cells was found to promote tumor growth and angiogenesis in vivo .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(79, 0), 'end':(79, 10), 'text':'These effects are mediated through the promotion of c-Met phosphorylation ,'}, {'start':(79, 11), 'end':(79, 22), 'text':'hence potentiating the autocrine HGF and c-Met signaling pathway [ ] .'}]}]}]}]}]}]}]}
279	293	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 1), 'text':'7 .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 7), 'text':'Regulation of Semaphorins and Plexins by Oncogenic Pathways'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(2, 0), 'end':(2, 19), 'text':'While semaphorins and plexins impose their pro- and antitumorigenic functions in gliomas through the regulation of various signaling pathways ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(2, 20), 'end':(2, 22), 'text':'accumulating evidence suggests'}, {'start':(2, 23), 'end':(2, 37), 'text':'that they are also targets for modulation by some of the aberrant oncogenic pathways .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(3, 0), 'end':(3, 1), 'text':'The gene'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(3, 2), 'end':(3, 9), 'text':'encoding for Sema3B for instance , was identified'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 10), 'end':(3, 19), 'text':'as a direct target of the tumor suppressor gene p53'}, {'start':(3, 20), 'end':(3, 28), 'text':'that is commonly mutated in gliomas [ ] .'}]}]}]}, {'start':(4, 0), 'end':(4, 32), 'text':'Ectopic expression of p53 in a p53 deficient glioblastoma cell line results in dramatic induction of Sema3B mRNA expression and a reduction in the number of colonies in anchorage independent growth assays .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(5, 0), 'end':(5, 2), 'text':'These findings suggest'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 3), 'end':(5, 7), 'text':'that Sema3B mediates the tumor'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 8), 'end':(5, 12), 'text':'suppressor functions of p53 ,'}, {'start':(5, 13), 'end':(5, 21), 'text':'which is often diminished in gliomas [ ] .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 16), 'text':'Hyperactivation of Ras and its downstream signaling cascades is another commonly observed genetic lesion in different cancers'}, {'start':(6, 17), 'end':(6, 19), 'text':'including gliomas .'}]}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(7, 0), 'end':(7, 17), 'text':'Oncogenic mutations of B-Raf , one of the effectors of Ras is prevalent in melanomas and other cancers'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 18), 'end':(7, 24), 'text':'but is rarely detected in gliomas ,'}, {'start':(7, 25), 'end':(7, 37), 'text':'which when present are mainly restricted to high-grade malignant glioblastomas [ ] .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 18), 'text':'In gliomas , gain in copy number is more common than mutations for Ras and Raf [ ] ,'}, {'start':(8, 19), 'end':(8, 33), 'text':'though both forms of deregulation lead to activation of the MEK and ERK pathway .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 20), 'text':'Interestingly , constitutive B-Raf/MEK/ERK signaling was found to be associated with a downregulation of plexin-B1 transcript in melanoma [ ] .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(10, 0), 'end':(10, 14), 'text':'Restoring plexin-B1 expression in melanoma cells is sufficient to suppress anchorage independent growth in vitro'}, {'start':(10, 15), 'end':(10, 25), 'text':'and inhibit tumor growth in xenograft transplants in nude mice .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(11, 0), 'end':(11, 10), 'text':'The antitumorigenic effect of plexin-B1 is dependent on its R-RasGAP activity'}, {'start':(11, 11), 'end':(11, 19), 'text':'and is associated with AKT inactivation [ ] .'}]}]}, {'start':(12, 0), 'end':(12, 23), 'text':'While R-Ras is less oncogenic than other Ras , its deregulation in gliomas is known to promote migration and invasion behaviors [ ] .'}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(13, 0), 'end':(13, 2), 'text':'It is plausible'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 3), 'end':(13, 8), 'text':'that the antitumorigenic functions of plexin-B1'}, {'start':(13, 9), 'end':(13, 18), 'text':'observed in melanoma are adopted in gliomas as well .'}]}]}]}
1	8	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 11), 'text':'Gliomas are the most common tumor in the central nervous system .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 12), 'text':'High-grade glioblastomas are characterized by their high invasiveness and resistance to radiotherapy ,'}, {'start':(1, 13), 'end':(1, 26), 'text':'leading to high recurrence rate and short median survival despite radical surgical resection .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'cause', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 22), 'text':'Characterizations of gliomas at molecular level have revealed aberrations of various growth factor receptors , receptor tyrosine kinases , and tumor suppressor genes'}, {'start':(2, 23), 'end':(2, 31), 'text':'that lead to deregulation of multiple signaling pathways ,'}]}, {'start':(2, 32), 'end':(2, 47), 'text':'thereby contributing to abnormal proliferation , invasion , and resistance to apoptosis in cancer cells .'}]}, {'start':(3, 0), 'end':(3, 16), 'text':'Recently , accumulating evidence points to the emerging role of axon guidance molecules in glioma progression .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 4), 'text':'Notably , many signaling events'}, {'start':(4, 5), 'end':(4, 8), 'text':'harnessed by guidance molecules'}]}, {'start':(4, 9), 'end':(4, 32), 'text':'to regulate cell migration and axon navigation during development are also found to be involved in the modulation of deregulated pathways in gliomas .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 1), 'text':'This paper'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 2), 'end':(5, 5), 'text':'focused on the signalings'}, {'label':'joint', 'direction':'None', 'children':[{'start':(5, 6), 'end':(5, 18), 'text':'triggered by the guidance molecule semaphorins and their receptors plexins and neuropilins ,'}, {'start':(5, 19), 'end':(5, 32), 'text':'and how their crosstalk with oncogenic pathways in gliomas might modulate cancer progression .'}]}]}]}]}]}]}, {'start':(6, 0), 'end':(6, 15), 'text':'The emerging role of semaphorins and plexins as tumor suppressors or oncogenes is also discussed .'}]}
258	279	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 1), 'text':'6 .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 8), 'text':'Coupling of Plexin-B with c-Met and ErbB2 as Coreceptors'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 5), 'text':'c-Met is a tyrosine kinase receptor'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(2, 6), 'end':(2, 20), 'text':'that upon stimulation by hepatocyte growth factor and scatter factor ( HGF and SF )'}, {'start':(2, 21), 'end':(2, 51), 'text':'regulates various cellular functions such as cell proliferation , migration , invasion , and morphogenesis through activation of various signalings such as the Ras and the PI3K and AKT pathways .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(3, 0), 'end':(3, 5), 'text':'They are commonly overexpressed in gliomas'}, {'start':(3, 6), 'end':(3, 13), 'text':'and contribute to enhanced tumorigenicity [ ] .'}]}]}, {'start':(4, 0), 'end':(4, 15), 'text':'An inhibition of endogenous HGF and SF and c-Met in gliomas suppresses the malignant phenotype .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 29), 'text':'To date , all known members of plexin-B subfamily have been shown to interact with c-Met and the related proto-oncogene Ron , even in the absence of their ligands .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 14), 'text':'Binding of Sema4D to plexin-B1 stimulates the tyrosine kinase activity of c-Met and Ron ,'}, {'start':(6, 15), 'end':(6, 39), 'text':'resulting in tyrosine phosphorylation of both receptors and promotion of invasive response in a liver progenitor cell line and a colon carcinoma cell line .'}]}, {'start':(7, 0), 'end':(7, 12), 'text':'By contrast , a recent study has reported the opposite in melanoma .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'cause', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 7), 'text':'Sema4D fails to activate c-Met in melanomas ,'}, {'start':(8, 8), 'end':(8, 20), 'text':'not because of a significant downregulation of plexin-B1 in these cancer cells .'}]}, {'start':(9, 0), 'end':(9, 18), 'text':'Instead , reconstitution of plexin-B1 expression in melanomas inhibits HGF dependent activation of c-Met and migration [ ] .'}]}]}]}, {'start':(10, 0), 'end':(10, 17), 'text':'A plausible explanation for this observation could be the competition between plexin-B1 and HGF for c-Met binding .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 16), 'text':'Importantly , restoring plexin-B1 expression in melanoma cells is sufficient to suppress tumor growth in vivo ,'}, {'start':(11, 17), 'end':(11, 26), 'text':'suggesting a tumor suppressor role of plexin-B1 [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(12, 0), 'end':(12, 9), 'text':'In fact , the contrasting effects of semaphorins and plexins'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 10), 'end':(12, 23), 'text':'in regulating HGF and c-Met signaling is not unexpected given the ability of plexins'}, {'start':(12, 24), 'end':(12, 34), 'text':'to modulate Ras and PI3K as described above ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 22), 'text':'In addition to c-Met , members of the plexin-B family were also found to stably associate with another receptor tyrosine kinase ErbB2 .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 13), 'text':'Binding of Sema4D to plexin-B1 stimulates the intrinsic tyrosine kinase activity of ErbB2 ,'}, {'start':(14, 14), 'end':(14, 23), 'text':'resulting in the phosphorylation of both receptors [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 17), 'text':'ErbB2 mediated phosphorylation of plexin-B1 is important for Sema4D induced activation of RhoA through PDZ-RhoGEF [ ] .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 17), 'text':'Contrary to this , Sema4D induces an inactivation of RhoA in a c-Met dependent manner [ ] .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 34), 'text':'The reciprocal effect of c-Met and ErbB2 in plexin-B1-mediated regulation of RhoA activation status is believed to partially account for the pro- and antimigratory effects of Sema4D in breast carcinoma and other cancer cells ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 35), 'end':(17, 39), 'text':'depending on the relative expression'}, {'start':(17, 40), 'end':(17, 47), 'text':'levels of these two receptors [ ] .'}]}]}, {'start':(18, 0), 'end':(18, 14), 'text':'Notably , analysis of astrocytomas of different grades shows no gene amplification of ErbB2 .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(19, 0), 'end':(19, 8), 'text':'The expression of ErbB2 protein is weaker than EGFR'}, {'start':(19, 9), 'end':(19, 22), 'text':'and is at barely detectable level by Western and immunocytochemistry analysis [ ] .'}]}]}]}]}]}]}]}]}]}, {'start':(20, 0), 'end':(20, 22), 'text':'The relative importance of c-Met and ErbB2 in the regulation of glioma behaviors by semaphorin and plexin signaling remains to be determined .'}]}]}
200	258	{'label':'joint', 'direction':'None', 'children':[{'start':(0, 0), 'end':(0, 1), 'text':'5 .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 3), 'text':'Semaphorin and Plexin Signalings'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 17), 'text':'Semaphorins and their receptors are inarguably involved in the progression of a large number of cancer types ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 18), 'end':(2, 19), 'text':'with functions'}, {'start':(2, 20), 'end':(2, 36), 'text':'ranging from cell migration , invasion , metastasis , proliferation , and apoptosis , to angiogenesis .'}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(3, 0), 'end':(3, 3), 'text':'It is not uncommon'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 4), 'end':(3, 16), 'text':'that many semaphorins can induce pro- and antitumorigenic effects in different cancers ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 17), 'end':(3, 21), 'text':'making it a challenging task'}, {'start':(3, 22), 'end':(3, 30), 'text':'to decipher the underlying mechanisms of these activities .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(4, 0), 'end':(4, 10), 'text':'For instance , Sema3B induces apoptosis in lung and breast cancer'}, {'label':'joint', 'direction':'None', 'children':[{'start':(4, 11), 'end':(4, 16), 'text':'but is associated with poor prognosis'}, {'start':(4, 17), 'end':(4, 24), 'text':'and survival of glioma patients [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 4), 'text':'Sema3A promotes glioblastoma cell dispersal'}, {'start':(5, 5), 'end':(5, 10), 'text':'but inhibits angiogenesis in meningiomas .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'cause', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 17), 'text':'Possible reasons for these diversities could be attributable to cross-interactions between different subfamilies of semaphorins and plexins ,'}, {'start':(6, 18), 'end':(6, 25), 'text':'which show differential binding affinity and specificity ,'}]}, {'start':(6, 26), 'end':(6, 35), 'text':'thereby triggering different sets of signaling events and functions .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(7, 0), 'end':(7, 9), 'text':'A second level of regulation is attained by coupling plexins'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 10), 'end':(7, 16), 'text':'and and or neuropilins to various coreceptors'}, {'start':(7, 17), 'end':(7, 45), 'text':'expressed in a cell- or tissue specific manner , such as neuropilins , L1-cell adhesion molecule , c-Met proto-oncogene , the receptor tyrosine kinase ErbB2 , and PDGFR .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 11), 'text':'This could potentially elicit a more diverse network of signaling events .'}, {'start':(9, 0), 'end':(9, 1), 'text':'5.1 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 4), 'text':'Plexin-A Signaling Regulates PI3K Pathway'}, {'start':(11, 0), 'end':(11, 15), 'text':'Sema3A signaling involves phosphorylation of plexin-As by nonreceptor tyrosine kinases Fes and Fps and Fyn .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(12, 0), 'end':(12, 11), 'text':'Fyn , a member of the Src family of tyrosine kinases ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(12, 12), 'end':(12, 13), 'text':'associates with'}, {'start':(12, 14), 'end':(12, 23), 'text':'and phosphorylates plexin-A2 in response to Sema3A ( ) .'}]}]}, {'start':(13, 0), 'end':(13, 12), 'text':'Active Fyn then phosphorylates cyclin dependent kinase-5 ( Cdk5 ) [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(14, 0), 'end':(14, 16), 'text':'While activated Cdk5 is classically known to phosphorylate CRMP-2 ( collapse response mediator protein ) in neurons'}, {'start':(14, 17), 'end':(14, 23), 'text':'and leads to growth cone collapse ,'}]}, {'label':'attribution', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(14, 24), 'end':(14, 28), 'text':'a recent report has shown'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 29), 'end':(14, 49), 'text':'that Cdk5 mediated phosphorylation of PIKE-A ( Isoform A of phosphatidylinositol 3-kinase enhancer ) , a novel pro-oncogenic and antiapoptotic factor'}, {'start':(14, 50), 'end':(14, 52), 'text':'that activates AKT'}]}, {'start':(14, 53), 'end':(14, 58), 'text':'and promotes cancer cell growth ,'}]}]}, {'start':(14, 59), 'end':(14, 65), 'text':'induces glioblastoma cell migration and invasion .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 9), 'text':'These signalings are consistent with the protumorigenic role of Sema3A'}, {'start':(15, 10), 'end':(15, 17), 'text':'in promoting glioma cell dispersal [ ] .'}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 9), 'text':'Interestingly , a recent report has provided in vivo evidence'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(16, 10), 'end':(16, 20), 'text':'that hyperactivated EGFR signaling in glioblastoma patients also recruits Fyn kinase'}, {'start':(16, 21), 'end':(16, 31), 'text':'to enhance tumor survival , growth and invasion [ ] .'}]}]}, {'start':(17, 0), 'end':(17, 1), 'text':'5.2 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 3), 'text':'Plexin-B Signaling Regulates RhoGTPases'}, {'start':(19, 0), 'end':(19, 29), 'text':'Stimulation of plexin-B1 with Sema4D has been shown to recruit active Rac1 to the Cdc42 and Rac interactive binding ( CRIB ) domain in the cytoplasmic tail [ ] .'}]}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 16), 'text':'This leads to sequestration of Rac1-GTP from its downstream effector p21 activated kinase ( PAK ) ,'}, {'start':(20, 17), 'end':(20, 28), 'text':'hence suppressing Rac1 mediated functions such as cell migration and proliferation .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 2), 'text':'A recent report'}, {'start':(21, 3), 'end':(21, 21), 'text':'that investigates the significance of Sema5A and plexin-B3 in glioma has also shown their suppression of Rac1 activation ,'}]}, {'start':(21, 22), 'end':(21, 27), 'text':'though through a different mechanism .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 13), 'text':'Sema5A stimulation of plexin-B3 promotes the recruitment of Rac1 to Rho GDP dissociation inhibitor'}, {'start':(22, 14), 'end':(22, 18), 'text':'( RhoGDI ) alpha ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 19), 'end':(22, 23), 'text':'which is a negative modulator'}, {'label':'joint', 'direction':'None', 'children':[{'start':(22, 24), 'end':(22, 27), 'text':'that sequesters small GTPases'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 28), 'end':(22, 35), 'text':'and shuttles them from membrane to the cytosol'}, {'start':(22, 36), 'end':(22, 41), 'text':'to prevent activation ( ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 37), 'text':'The inactivation of Rac1 was confirmed to contribute to Sema5A induced impediment of glioma cell migration and invasion , as evident by the abolishment of effect upon forced expression of a constitutively active Rac1 mutant [ ] .'}, {'start':(24, 0), 'end':(24, 15), 'text':'In addition to Rac1 , plexin-Bs are also involved in the regulation of RhoA activation .'}]}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 15), 'text':'Plexin-B members are peculiar to feature a PDZ domain binding motif at their carboxyl terminus .'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 0), 'end':(26, 13), 'text':'A number of studies have demonstrated direct interaction of plexin-B1 with two PDZ domain'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 14), 'end':(26, 28), 'text':'containing Rho guanine nucleotide exchange factors ( RhoGEF ) , namely , PDZ-RhoGEF and leukemia'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 29), 'end':(26, 30), 'text':'associated RhoGEF'}, {'start':(26, 31), 'end':(26, 37), 'text':'( LARG ) [ - ] .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 16), 'text':'Stimulation of plexin-B1 by Sema4D leads to RhoA activation in a PDZ-RhoGEF and LARG dependent manner ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 17), 'end':(27, 21), 'text':'causing remodeling of actin cytoskeleton'}, {'start':(27, 22), 'end':(27, 34), 'text':'that is important for the regulation of cell morphology and cell motility .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 0), 'end':(28, 10), 'text':'Notably , Sema4D is known to activate the MAPK pathway ,'}, {'start':(28, 11), 'end':(28, 27), 'text':'which is dependent on the C-terminus of plexin-B1 and LARG mediated activation of RhoA [ ] .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(29, 0), 'end':(29, 10), 'text':'In fact , RhoA-GTP was formerly shown to signal to Raf'}, {'start':(29, 11), 'end':(29, 17), 'text':'to activate MAPK cascade [ ] .'}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(30, 0), 'end':(30, 2), 'text':'Taken together ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 3), 'end':(30, 9), 'text':'this provides a link between the signalings'}, {'start':(30, 10), 'end':(30, 15), 'text':'mediated by Sema4D and MAPK .'}]}]}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(31, 0), 'end':(31, 5), 'text':'However , it should be emphasized'}, {'start':(31, 6), 'end':(31, 37), 'text':'that the activation of RhoA through PDZ-RhoGEF represents a specific mode restricted to members of the plexin-B subfamily due to the exclusive presence of PDZ domain binding motif in their C-terminus .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 0), 'end':(32, 9), 'text':'On the other hand , there is also opposing evidence'}, {'start':(32, 10), 'end':(32, 20), 'text':'that indicates the role of Sema4D in RhoA inactivation instead .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(33, 0), 'end':(33, 6), 'text':'Stimulation of plexin-B1 with Sema4D was found'}, {'start':(33, 7), 'end':(33, 15), 'text':'to promote the binding of plexin-B1 with p190-RhoGAP ,'}]}, {'start':(33, 16), 'end':(33, 18), 'text':'which inactivates RhoA'}]}, {'start':(33, 19), 'end':(33, 28), 'text':'and leads to disassembly of focal adhesions [ ] .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 21), 'text':'Interestingly , the GAP activity of p190-RhoGAP is enhanced by direct interaction with the constitutively active small GTPase Rnd1 [ ] ,'}, {'start':(34, 22), 'end':(34, 33), 'text':'which also binds to the intracellular domain of plexin-B1 [ ] .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(35, 0), 'end':(35, 4), 'text':'It remains to be determined'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(35, 5), 'end':(35, 11), 'text':'whether plexin-B1 serves as a docking site'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(35, 12), 'end':(35, 24), 'text':'to facilitate p190-RhoGAP activation by Rnd1 or instead functions as a negative regulator'}, {'start':(35, 25), 'end':(35, 30), 'text':'by sequestering Rnd1 from p190RhoGAP .'}]}]}]}]}, {'start':(36, 0), 'end':(36, 1), 'text':'5.3 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 0), 'end':(37, 4), 'text':'Plexin Singaling Regulates Ras Activity'}, {'start':(38, 0), 'end':(38, 16), 'text':'Sequence analysis of plexins revealed the presence of weakly conserved RasGAP motifs in the cytoplasmic domain .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 0), 'end':(39, 8), 'text':'A closer examination revealed two subdomains C1 and C2'}, {'start':(39, 9), 'end':(39, 27), 'text':'which harbor the primary arginine ( Arg ) finger and the secondary Arg and Lys motif , respectively ,'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(39, 28), 'end':(39, 37), 'text':'which are highly conserved in the catalytic domain of GAPs'}, {'start':(39, 38), 'end':(39, 50), 'text':'and are essential for promoting the GTP hydrolytic activity of target GTPases .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 0), 'end':(40, 18), 'text':'The intervening region between C1 and C2 encompasses the binding site for active Rac1 and constitutively active Rnd1 .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 12), 'text':'In basal state , C1 and C2 domains in plexin-B1 undergo intramolecular interaction'}, {'start':(41, 13), 'end':(41, 19), 'text':'that prevents their association with Ras .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(42, 0), 'end':(42, 9), 'text':'Rnd1 binding to the linker region relieves the closed conformation'}, {'start':(42, 10), 'end':(42, 19), 'text':'and allows the plexin-B1-Rnd1 complex to interact with R-Ras .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'condition', 'direction':'LeftToRight', 'children':[{'start':(43, 0), 'end':(43, 6), 'text':'However , RasGAP activity is not triggered'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 7), 'end':(43, 13), 'text':'until Sema4D binds to Rnd-1-bound plexin-B1 ,'}, {'start':(43, 14), 'end':(43, 20), 'text':'which causes dimerization of the receptor .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(44, 0), 'end':(44, 25), 'text':'The inactivation of R-Ras by GAP activity of plexin-B1 contributes to the inhibition of neurite outgrowth and growth cone collapse in hippocampal neurons by Sema4D .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(45, 0), 'end':(45, 10), 'text':'Notably , this GAP domain is conserved throughout all plexin families'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 11), 'end':(45, 20), 'text':'and has been shown to mediate repulsion of axon outgrowth'}, {'start':(45, 21), 'end':(45, 30), 'text':'induced by Sema3A and plexin-A1 as well [ ] .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 0), 'end':(46, 6), 'text':'In contrast to other Ras family members'}, {'start':(46, 7), 'end':(46, 13), 'text':'that are commonly deregulated in gliomas ,'}]}, {'start':(46, 14), 'end':(46, 25), 'text':'R-Ras only weakly activates Raf and the MEK and ERK pathway .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 0), 'end':(47, 17), 'text':'Instead , R-Ras stimulates PI3K and AKT with an efficiency comparable to that of Ras ( ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(48, 0), 'end':(48, 21), 'text':'R-Ras has been shown to promote breast carcinoma cell migration and invasion in a PI3K- and integrin dependent manner [ ] .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 0), 'end':(49, 8), 'text':'Inactivation of R-Ras by the RasGAP activity of plexin-B1'}, {'start':(49, 9), 'end':(49, 31), 'text':'triggered by Sema4D was shown to cause an inhibition of cell migration through suppression of PI3K and beta1 integrin activity [ ] .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(50, 0), 'end':(50, 5), 'text':'Recently , there has been evidence'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(50, 6), 'end':(50, 7), 'text':'to show'}, {'start':(50, 8), 'end':(50, 35), 'text':'that the inactivation of R-Ras by Sema4D induced RasGAP activity of plexin-B1 leads to PTEN dephosphorylation , thereby activating its inhibitory effect on PI3K signaling [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 0), 'end':(51, 4), 'text':'This provides a plausible mechanism'}, {'start':(51, 5), 'end':(51, 14), 'text':'by which plexin-Bs regulates the PI3K and AKT pathway .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 0), 'end':(52, 19), 'text':'While the importance of R-Ras activity regulation by semaphorin and plexin in glioma progression is yet to be scrutinized ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(52, 20), 'end':(52, 33), 'text':'increasing R-Ras expression and activation is known to correlate with advanced grades of gliomas'}, {'start':(52, 34), 'end':(52, 40), 'text':'and invading glioblastoma cells [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 0), 'end':(53, 13), 'text':'In addition to R-Ras , Sema4D and plexin-B1 can also suppress M-Ras activity ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(53, 14), 'end':(53, 21), 'text':'which results in an inhibition of dendritic outgrowth'}, {'start':(53, 22), 'end':(53, 30), 'text':'and branching in primary cortical neurons [ ] .'}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'LeftToRight', 'children':[{'start':(54, 0), 'end':(54, 13), 'text':'Remarkably , this signaling was found to induce a suppression of ERK activity ,'}, {'start':(54, 14), 'end':(54, 19), 'text':'though the mechanism remains known .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(55, 0), 'end':(55, 2), 'text':'It is notable'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 3), 'end':(55, 17), 'text':'that a recent study has reported Rap1 as a novel substrate for the GAP activity'}, {'start':(55, 18), 'end':(55, 21), 'text':'mediated by plexin-B1 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(56, 0), 'end':(56, 10), 'text':'Rap1 overexpression was observed in astrocytomas of all malignancy grades ,'}, {'start':(56, 11), 'end':(56, 32), 'text':'and was 2 to 3 folds higher in grade IV GBMs than in lower grades or non neoplastic brain [ ] .'}]}, {'start':(57, 0), 'end':(57, 22), 'text':'The effect of GAP activity of plexin-B on Rap1 in the control of glioma progression , if any , warrants further investigations .'}]}]}]}]}]}]}
19	58	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 1), 'text':'2 .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 2), 'text':'Classification of Astrocytomas'}, {'start':(2, 0), 'end':(2, 9), 'text':'Astrocytomas can be categorized into localized and diffuse forms .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 14), 'text':'Localized astrocytic tumors exhibit a circumscribed growth pattern with limited capacity for parenchymal infiltration .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 8), 'text':'Pilocytic astrocytomas for instance , are slow growing tumors'}, {'start':(4, 9), 'end':(4, 19), 'text':'that occur primarily in children or young adults [ ] .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(5, 0), 'end':(5, 3), 'text':'They are mostly nonaggressive'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 4), 'end':(5, 9), 'text':'and show little or no tendency'}, {'start':(5, 10), 'end':(5, 15), 'text':'to undergo anaplastic malignant transformation .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(6, 0), 'end':(6, 6), 'text':'This type of astrocytic tumor is classified'}, {'label':'condition', 'direction':'LeftToRight', 'children':[{'start':(6, 7), 'end':(6, 14), 'text':'as WHO grade I and is often curable'}, {'start':(6, 15), 'end':(6, 20), 'text':'if the tumor is resectable .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 10), 'text':'Histologically , Rosenthal fibers are often observed on tumor sections .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 19), 'text':'By contrast , diffuse astrocytomas are characterized by their high infiltration into peritumoral regions and dispersal to distant sites .'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(9, 0), 'end':(9, 5), 'text':'Based on the WHO classification ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 6), 'end':(9, 11), 'text':'they are subdivided into low-grade astrocytoma'}, {'start':(9, 12), 'end':(9, 30), 'text':'( grade II ) , anaplastic astrocytoma ( grade III ) , and glioblastoma multiforme ( GBM ) .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(10, 0), 'end':(10, 7), 'text':'Low-grade diffuse astrocytoma is characterized by slow growth'}, {'start':(10, 8), 'end':(10, 16), 'text':'and infiltration of neighboring brain structures [ ] .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(11, 0), 'end':(11, 11), 'text':'Histologically , the tumors are characterized by low to moderate cellularity .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(12, 0), 'end':(12, 4), 'text':'Cancer cells are well differentiated'}, {'start':(12, 5), 'end':(12, 14), 'text':'and show resemblance to astrocytes with little nuclear atypia .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(13, 0), 'end':(13, 5), 'text':'Also known as fibrillary astrocytomas ,'}, {'start':(13, 6), 'end':(13, 15), 'text':'these cancers are believed to arise from neoplastic astrocytes .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 8), 'text':'In fact , the cancer cells produce cytoplasmic processes'}, {'start':(14, 9), 'end':(14, 18), 'text':'that form a rich fibrillary stroma around the neoplasm ,'}]}, {'start':(14, 19), 'end':(14, 31), 'text':'hence giving rise to a diffuse outline of the tumor in scans .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(15, 0), 'end':(15, 12), 'text':'These grade II tumors typically affect young adults ( age of 25-50 )'}, {'start':(15, 13), 'end':(15, 27), 'text':'and are treatable , with a mean survival of 6 years after surgical intervention .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 11), 'text':'Nonetheless , the prognosis varies because of the tendency for these tumors'}, {'start':(16, 12), 'end':(16, 19), 'text':'to undergo malignant transformation to higher grades .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 7), 'text':'Anaplastic astrocytoma is highly proliferative and infiltrative .'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(18, 0), 'end':(18, 3), 'text':'It is not uncommon'}, {'label':'joint', 'direction':'None', 'children':[{'start':(18, 4), 'end':(18, 17), 'text':'that cells of these grade III malignant tumors invade along the white matter tracts'}, {'start':(18, 18), 'end':(18, 34), 'text':'and give rise to a classic " butterfly " pattern of spread at the corpus callosum .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(19, 0), 'end':(19, 9), 'text':'While histological characteristics of astrocytes can still be observed ,'}, {'start':(19, 10), 'end':(19, 20), 'text':'the tumor cells become more pleomorphic with distinct nuclear atypia .'}]}, {'start':(20, 0), 'end':(20, 7), 'text':'They show increased mitotic activity and cellularity .'}]}, {'start':(21, 0), 'end':(21, 22), 'text':'Notably , anaplastic astrocytoma may develop de novo as primary tumor or arise from a grade II diffuse astrocytoma as secondary tumor .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 9), 'text':'Afflicted patients are usually around the age of 40 .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 10), 'text':'Treatment regimens include surgical resection , radiation , and chemotherapy .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 19), 'text':'Owing to the high invasiveness and aggressiveness , however , high recurrence rate is often observed within 2 years ,'}, {'start':(24, 20), 'end':(24, 31), 'text':'during which the cancer typically would have progressed to high-grade glioblastoma .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(25, 0), 'end':(25, 11), 'text':'GBM is the most invasive and malignant form of diffuse astrocytomas ,'}, {'start':(25, 12), 'end':(25, 23), 'text':'and is one of the most aggressive type of human neoplasms .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(26, 0), 'end':(26, 6), 'text':'Histologically , the cancer cells are anaplastic'}, {'start':(26, 7), 'end':(26, 10), 'text':'and poorly differentiated .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 13), 'text':'The pleomorphic astrocytic tumor cells show marked nuclear atypia and high mitotic activity .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'LeftToRight', 'children':[{'start':(28, 0), 'end':(28, 12), 'text':'Rapid proliferation of the malignant cancer cells is accompanied by microvascular proliferation ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 13), 'end':(28, 18), 'text':'though hypoxia is often resulted ,'}, {'start':(28, 19), 'end':(28, 26), 'text':'leading to necrosis in the tumor core .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 0), 'end':(29, 22), 'text':'In fact , neovascularization and necrotic cell death are the two major histopathological hallmarks for the diagnosis of glioblastomas versus anaplastic astrocytomas .'}, {'start':(30, 0), 'end':(30, 9), 'text':'Glioblastomas can be subdivided into primary or secondary form .'}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 14), 'text':'Primary GBMs account for 60 % of cases in adults above 45 years old .'}, {'start':(32, 0), 'end':(32, 15), 'text':'These tumors arise de novo with no sign of a preexisting less malignant precursor lesion .'}]}, {'start':(33, 0), 'end':(33, 33), 'text':'In contrast , secondary GBMs typically develop in patients below the age of 45 through malignant progression from lower grade diffuse astrocytoma or anaplastic astrocytoma in a span of one to ten years .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 14), 'text':'At molecular level , the genetic lesions in primary and secondary GBMs also differ .'}, {'start':(35, 0), 'end':(35, 17), 'text':'Glioblastoma occurs most frequently in the cerebral hemisphere of adults between the ages of 45 and 70 .'}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(36, 0), 'end':(36, 8), 'text':'Owing to the wide infiltration of glioblastoma cells ,'}, {'start':(36, 9), 'end':(36, 18), 'text':'it is impossible to eradicate them by surgical means .'}]}]}, {'start':(37, 0), 'end':(37, 19), 'text':'In addition to their resistance to radio- and chemotherapy , recurrence rate of GBMs is close to 100 % .'}]}]}]}, {'start':(38, 0), 'end':(38, 20), 'text':'A median survival of approximately one year is therefore commonly seen in the afflicted patients despite aggressive multimodality treatment regimens .'}]}]}
8	19	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 1), 'text':'1 .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(1, 0), 'end':(1, 0), 'text':'Introduction'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 28), 'text':'Gliomas are the most common tumor in the central nervous system , with an incidence rate of 5 to 10 per 100,000 for the malignant form [ ] .'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(3, 0), 'end':(3, 10), 'text':'Based on their histological characteristics and expression of lineage markers ,'}, {'start':(3, 11), 'end':(3, 24), 'text':'gliomas can be classified into astrocytoma , oligodendroglioma , and ependymoma [ ] .'}]}]}]}, {'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 28), 'text':'Astrocytomas account for 60 % of all primary brain tumors and the World Health Organization ( WHO ) classification system grades them on a scale of I to IV'}, {'start':(4, 29), 'end':(4, 38), 'text':'according to their increasing degree of malignancy [ ] .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 17), 'text':'Among them , Grade IV is one of the most highly invasive types of tumor [ ] ,'}, {'start':(5, 18), 'end':(5, 22), 'text':'characterized by microvascular proliferation .'}]}, {'start':(6, 0), 'end':(6, 22), 'text':'Its aggressive infiltrative growth leads to an extremely high recurrence rate within a short period of time even after radical surgical resection .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 21), 'text':'Worse still , many glioblastomas are found to be resistant to chemo- or radiotherapy due to DNA repair by the protein O6-methylguanine-methyltransferase'}, {'start':(7, 22), 'end':(7, 29), 'text':'( MGMT ) and impaired apoptotic pathways .'}]}, {'start':(8, 0), 'end':(8, 16), 'text':'Median survival after initial diagnosis is therefore currently only around 12 to 18 months [ ] .'}]}]}, {'start':(9, 0), 'end':(9, 29), 'text':'This apparently calls for a more thorough understanding of the pathoetiology at both cellular and molecular level to provide insight into the devise of novel and effective therapeutic treatments .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 9), 'text':'This paper revisits the biological features of various genetic pathways'}, {'start':(10, 10), 'end':(10, 14), 'text':'deregulated in human gliomas ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 15), 'end':(10, 29), 'text':'followed by an overview of the involvement of semaphorins and their receptors in these signalings'}, {'start':(10, 30), 'end':(10, 41), 'text':'that lead to their emerging role in the regulation of gliomagenesis .'}]}]}]}
293	303	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 1), 'text':'8 .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 1), 'text':'Concluding Remarks'}, {'start':(2, 0), 'end':(2, 21), 'text':'Gliomas are known to exhibit not only histological heterogeneity but also variations in genetic alterations both inter- and intratumorally [ ] .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 5), 'text':'These have led to the proposition'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(3, 6), 'end':(3, 13), 'text':'to incorporate molecular signature to classical histopathological diagnosis'}, {'start':(3, 14), 'end':(3, 29), 'text':'so as to provide a more informative description of the features of different glioma types .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 7), 'text':'Here , an overview of various signaling pathways'}, {'start':(4, 8), 'end':(4, 14), 'text':'commonly deregulated in gliomas was presented .'}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 3), 'text':'Despite our increasing knowledge'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 4), 'end':(5, 13), 'text':'of how these oncogenic pathways interact in a complex manner'}, {'start':(5, 14), 'end':(5, 18), 'text':'to contribute to aberrant cell'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(5, 19), 'end':(5, 26), 'text':'proliferation , resistance to apoptotic cell death ,'}, {'start':(5, 27), 'end':(5, 39), 'text':'enhanced migration and invasion , and induction of angiogenesis in glioma cells ,'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 40), 'end':(5, 56), 'text':'the options of clinical treatment are still currently largely limited to a combination of surgical resection ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 57), 'end':(5, 61), 'text':'followed by radiotherapy or chemotherapy'}, {'start':(5, 62), 'end':(5, 69), 'text':'using nonspecific alkylating agents such as temozolomide .'}]}]}]}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 6), 'text':'While a number of inhibitors and antibodies'}, {'start':(6, 7), 'end':(6, 35), 'text':'that suppress the activities of deregulated kinases such as EGFR , c-MET , PDGFR , and PI3K are currently in difference phases of preclinical characterizations or clinical trials ,'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(6, 36), 'end':(6, 40), 'text':'the outcomes show great variations'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 41), 'end':(6, 45), 'text':'and are complicated by toxicity'}, {'start':(6, 46), 'end':(6, 50), 'text':'associated with the agents .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 21), 'text':'The emerging roles of semaphorins and their receptors in the regulation of gliomagenesis and progression therefore represent potential novel candidate targets .'}, {'start':(8, 0), 'end':(8, 33), 'text':'Given the engagement of plexins with some of the oncogenic receptor tyrosine kinases such as c-Met and ErbB2 as coreceptors , a better understanding of the crosstalk between these signaling networks is required .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 4), 'text':'Supported by the recent success'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(9, 5), 'end':(9, 12), 'text':'in detecting MGMT methylation level in glioblastoma patients'}, {'start':(9, 13), 'end':(9, 18), 'text':'to predict their sensitivity to chemoradiotherapy'}]}, {'start':(9, 19), 'end':(9, 22), 'text':'using alkylating agents ,'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 23), 'end':(9, 30), 'text':'future direction in clinical management of gliomas ,'}, {'start':(9, 31), 'end':(9, 36), 'text':'which are heterogeneous in nature ,'}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(9, 37), 'end':(9, 50), 'text':'is to define the molecular and genetic profile of the tumor in individual patient'}, {'start':(9, 51), 'end':(9, 60), 'text':'so as to devise a customized regimen of treatments .'}]}]}]}]}]}]}
